Prostate News and Research

RSS
Major UK trial to examine role of aspirin in cancer recurrence

Major UK trial to examine role of aspirin in cancer recurrence

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

TGen researchers join international scientists in discovering how malaria protein could some day help stop cancer

TGen researchers join international scientists in discovering how malaria protein could some day help stop cancer

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Antibiotic resistance potentially threatens the safety and efficacy of surgical procedures and immunosuppression therapies

Antibiotic resistance potentially threatens the safety and efficacy of surgical procedures and immunosuppression therapies

Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries

Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries

Researchers find significant link between breast cancer and nutrition, explore new preventative treatment

Researchers find significant link between breast cancer and nutrition, explore new preventative treatment

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

SonaCare Medical's Sonablate 450 focused ultrasound system receives FDA approval for ablation of prostate tissue

SonaCare Medical's Sonablate 450 focused ultrasound system receives FDA approval for ablation of prostate tissue

Malaria protein could one day help stop cancer

Malaria protein could one day help stop cancer

Danish researchers face possible breakthrough in fight against cancer

Danish researchers face possible breakthrough in fight against cancer

High Intensity Focused Ultrasound treatment now available in the U.S. to treat prostate cancer

High Intensity Focused Ultrasound treatment now available in the U.S. to treat prostate cancer

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Study highlights need for dietary interventions in cancer survivors

Study highlights need for dietary interventions in cancer survivors

Prostate Cells Undergo 'Reprogramming' To Form Tumors, Study Finds

Prostate Cells Undergo 'Reprogramming' To Form Tumors, Study Finds

IU investigators find how cancer-induced bone destruction triggers skeletal muscle weakness

IU investigators find how cancer-induced bone destruction triggers skeletal muscle weakness

Study identifies four distinct types of bowel cancer

Study identifies four distinct types of bowel cancer

YK-4-279 compound works against some forms of leukemia: Study

YK-4-279 compound works against some forms of leukemia: Study

Cancer survival outcomes can vary widely among U.S. hospitals

Cancer survival outcomes can vary widely among U.S. hospitals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.